Filter News
Area of Research
- Advanced Manufacturing (2)
- Biology and Environment (13)
- Clean Energy (42)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (2)
- Computer Science (5)
- Electricity and Smart Grid (1)
- Fusion and Fission (11)
- Fusion Energy (9)
- Materials (33)
- Materials for Computing (3)
- National Security (12)
- Neutron Science (64)
- Nuclear Science and Technology (5)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (40)
News Type
News Topics
- (-) Frontier (16)
- (-) Fusion (26)
- (-) Grid (37)
- (-) Machine Learning (25)
- (-) Mercury (5)
- (-) Neutron Science (78)
- (-) Summit (27)
- 3-D Printing/Advanced Manufacturing (76)
- Advanced Reactors (24)
- Artificial Intelligence (48)
- Big Data (24)
- Bioenergy (39)
- Biology (40)
- Biomedical (28)
- Biotechnology (11)
- Buildings (35)
- Chemical Sciences (43)
- Clean Water (15)
- Climate Change (46)
- Composites (20)
- Computer Science (101)
- Coronavirus (28)
- Critical Materials (23)
- Cybersecurity (20)
- Decarbonization (31)
- Education (3)
- Element Discovery (1)
- Energy Storage (74)
- Environment (81)
- Exascale Computing (11)
- Fossil Energy (2)
- High-Performance Computing (41)
- Hydropower (6)
- Irradiation (2)
- Isotopes (23)
- ITER (5)
- Materials (95)
- Materials Science (87)
- Mathematics (2)
- Microelectronics (1)
- Microscopy (27)
- Molten Salt (8)
- Nanotechnology (38)
- National Security (21)
- Net Zero (5)
- Nuclear Energy (46)
- Partnerships (30)
- Physics (28)
- Polymers (21)
- Quantum Computing (15)
- Quantum Science (38)
- Renewable Energy (1)
- Security (13)
- Simulation (16)
- Space Exploration (13)
- Statistics (2)
- Sustainable Energy (75)
- Transformational Challenge Reactor (4)
- Transportation (61)
Media Contacts
A team of researchers associated with the Quantum Science Center headquartered at the Department of Energy's Oak Ridge National Laboratory has confirmed the presence of quantum spin liquid behavior in a new material with a triangular lattice, KYbSe2.
Researchers at ORNL have been leading a project to understand how a high-altitude electromagnetic pulse, or EMP, could threaten power plants.
Currently, the biggest hurdle for electric vehicles, or EVs, is the development of advanced battery technology to extend driving range, safety and reliability.
Using neutrons to see the additive manufacturing process at the atomic level, scientists have shown that they can measure strain in a material as it evolves and track how atoms move in response to stress.
ORNL has been selected to lead an Energy Earthshot Research Center, or EERC, focused on developing chemical processes that use sustainable methods instead of burning fossil fuels to radically reduce industrial greenhouse gas emissions to stem climate change and limit the crisis of a rapidly warming planet.
The Department of Energy’s Oak Ridge National Laboratory announced the establishment of the Center for AI Security Research, or CAISER, to address threats already present as governments and industries around the world adopt artificial intelligence and take advantage of the benefits it promises in data processing, operational efficiencies and decision-making.
The Spallation Neutron Source — already the world’s most powerful accelerator-based neutron source — will be on a planned hiatus through June 2024 as crews work to upgrade the facility. Much of the work — part of the facility’s Proton Power Upgrade project — will involve building a connector between the accelerator and the planned Second Target Station.
A licensing agreement between the Department of Energy’s Oak Ridge National Laboratory and research partner ZEISS will enable industrial X-ray computed tomography, or CT, to perform rapid evaluations of 3D-printed components using ORNL’s machine
Technologies developed by researchers at ORNL have received six 2023 R&D 100 Awards.
After a highly lauded research campaign that successfully redesigned a hepatitis C drug into one of the leading drug treatments for COVID-19, scientists at ORNL are now turning their drug design approach toward cancer.